A joint panel meeting of FDA Metabolic &Endocrinologic Drugs and Drug Safety &Risk Management advisory committees on July 30 showcased a fissure between OND and OSE.

• 一个联合小组会议林业局新陈代谢及内分泌药物和药物的安全与风险管理咨询委员会于7月30日演示了裂隙之间ond和奥斯陆证券交易所。